Biofield Therapy for the Support of Immunotherapy-related Symptoms Among Adult Cancer Patients - A Pilot Study

Inclusion Criteria

• •Participants must be greater than 18 years of age.
• •Currently diagnosed with cancer.
• •Actively receiving immunotherapy treatment with ICI (PD1 or -PD-L1 inhibitor (single-agent immunotherapy or immunotherapy in combination with other agents; also including the use of steroids if applicable)
• •Report clinically significant fatigue over the past 7 days.
• •Able to travel to the study site to receive Reiki treatments once a week.
• •Understanding and willing to complete all study procedures.
• •Capable of giving written informed consent.
• •Proficient ability to speak, read, and write in English or Spanish.